EUVIMEDEUVIMED entdecken
Vergleichsstudie

Outcomes of prosthetic and biological grafts compared to arm vein grafts in patients with chronic limb-threatening ischemia

Mohammed Hamouda, Sina Zarrintan, Nishita Vootukuru, Sneha Thandra, Jon G Quatromoni, Mahmoud B Malas, Ann C Gaffey

Journal of Vascular Surgery · 2025-03 · 81 (3) · 682-692

DOI: 10.1016/j.jvs.2024.10.069 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2025-03. Verfasst von Mohammed Hamouda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular & Endovascular Surgery, Department of Surgery, Center for Learning and Excellence in Vascular and Endovascular Surgery (CLEVER),…. Hauptthemen laut MEDLINE: Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation, Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The optimal conduit for infrainguinal bypass (IIB) is single-segment great saphenous vein (GSV). Unfortunately, GSV is not always available in patients with chronic limb-threatening ischemia (CLTI). Other graft choices include arm vein grafts (AVs), prosthetic grafts (PGs), or biologic grafts (BGs). Current data regarding the durability and limb salvage rates of those options is scarce; hence, we aimed to investigate the impact of alternative graft types on postoperative and long-term outcomes on IIB in patients with CLTI. METHODS: The Vascular Quality Initiative (VQI) database was queried for patients undergoing IIB from January 2003 to April 2024. Patients were stratified into three groups: AVs (cephalic, basilic), PGs (Dacron, polytetrafluoroethylene [PTFE]), and BGs (cadaveric, homograft, or xenograft). Saphenous vein grafts (greater and lesser saphenous) were excluded. Multivariate logistic regression analyzed postoperative outcomes: 30-day mortality, major adverse cardiovascular events, graft occlusion, prolonged length of stay >7 days, packed red blood cell transfusion >2 units, and infection. Cox regression was used to report 1-year outcomes: mortality, major amputation (above-ankle), and major adverse limb events (defined as major amputation, thrombectomy, or reintervention). RESULTS: A total of 9165 IIB procedures have been analyzed: AV, 417 (4.55%); PG, 7520 (82.05%); and BG, 1228 (13.40%). Compared with AVs, patients receiving PGs had higher odds of infection (adjusted odds ratio [aOR], 2.89; P = .045) and higher hazard of 1-year mortality (adjusted hazard ratio [aHR], 1.51; P = .035). On the other hand, patients receiving BGs had higher risk of graft occlusion (aOR, 4.55; P = .040) and infection (aOR, 2.78; P = .046), as well as higher hazard of 1-year mortality (aHR, 1.53; P = .040), amputation (aHR, 1.72; P = .019), and amputation or death (aHR, 1.52; P = .005) compared with patients receiving AVs. After stratifying by bypass configuration, patients with AVs had the highest overall survival and amputation-free survival among the three alternative conduits in below-knee popliteal and tibial bypass targets. CONCLUSIONS: In this large multi-institutional study investigating alternative conduits to GSV, AVs are found to be the most resistant to infections and are associated with the best overall survival and limb salvage outcomes compared with PGs and BGs, particularly in below-knee distal targets. In cases where no GSV is available, AVs and PGs are acceptable alternatives with comparable 1-year amputation-free survival and major adverse limb events-free survival rates. On the other hand, BGs are associated with higher risk of graft occlusion and lower freedom from major amputation and death compared with AVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Vessel ProsthesisBlood Vessel Prosthesis ImplantationChronic Limb-Threatening IschemiaPeripheral Arterial DiseaseIschemiaBioprosthesisVeinsHumansFemaleMaleAgedLimb SalvageRetrospective StudiesTime FactorsTreatment OutcomeMiddle AgedRisk FactorsDatabases, FactualRisk AssessmentAmputation, SurgicalProsthesis DesignVascular PatencyGraft Occlusion, VascularAged, 80 and overSaphenous Vein

Stichwörter der Autor:innen

Arm veinCLTICryopreservedDacronGreat saphenous veinInfrainguinal bypassLower extremity bypassPTFE

Autor:innen und Institutionen

  • Division of Vascular & Endovascular Surgery, Department of Surgery, Center for Learning and Excellence in Vascular and Endovascular Surgery (CLEVER), UC San Diego (UCSD), San Diego, CA.
  • Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ.
  • Department of Vascular Surgery, Heart & Vascular Institute, Cleveland Clinic, Cleveland, OH.
  • Division of Vascular & Endovascular Surgery, Department of Surgery, Center for Learning and Excellence in Vascular and Endovascular Surgery (CLEVER), UC San Diego (UCSD), San Diego, CA. Electronic address: agaffey@healt…

Zitieren

APA

Hamouda, M., Zarrintan, S., Vootukuru, N., Thandra, S., Quatromoni, J. G., Malas, M. B., & Gaffey, A. C. (2025). Outcomes of prosthetic and biological grafts compared to arm vein grafts in patients with chronic limb-threatening ischemia. Journal of Vascular Surgery, 81(3), 682-692. https://doi.org/10.1016/j.jvs.2024.10.069

Vancouver

Hamouda M, Zarrintan S, Vootukuru N, Thandra S, Quatromoni JG, Malas MB, et al. Outcomes of prosthetic and biological grafts compared to arm vein grafts in patients with chronic limb-threatening ischemia. Journal of Vascular Surgery. 2025;81(3):682-692. doi:10.1016/j.jvs.2024.10.069

BibTeX
@article{Hamouda2025,
  author = {Hamouda, Mohammed and Zarrintan, Sina and Vootukuru, Nishita and Thandra, Sneha and Quatromoni, Jon G and Malas, Mahmoud B and Gaffey, Ann C},
  title = {Outcomes of prosthetic and biological grafts compared to arm vein grafts in patients with chronic limb-threatening ischemia},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  volume = {81},
  number = {3},
  pages = {682--692},
  doi = {10.1016/j.jvs.2024.10.069}
}
Kostenlos starten →